AKRO
Price
$41.68
Change
-$0.44 (-1.04%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
3.35B
70 days until earnings call
BEAM
Price
$25.69
Change
-$2.79 (-9.80%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
2.38B
63 days until earnings call
Ad is loading...

AKRO vs BEAM

Header iconAKRO vs BEAM Comparison
Open Charts AKRO vs BEAMBanner chart's image
Akero Therapeutics
Price$41.68
Change-$0.44 (-1.04%)
Volume$20.64K
Capitalization3.35B
Beam Therapeutics
Price$25.69
Change-$2.79 (-9.80%)
Volume$63.13K
Capitalization2.38B
AKRO vs BEAM Comparison Chart
Loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKRO vs. BEAM commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKRO is a StrongBuy and BEAM is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (AKRO: $42.12 vs. BEAM: $28.48)
Brand notoriety: AKRO and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKRO: 63% vs. BEAM: 100%
Market capitalization -- AKRO: $3.35B vs. BEAM: $2.38B
AKRO [@Biotechnology] is valued at $3.35B. BEAM’s [@Biotechnology] market capitalization is $2.38B. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKRO’s FA Score shows that 0 FA rating(s) are green whileBEAM’s FA Score has 0 green FA rating(s).

  • AKRO’s FA Score: 0 green, 5 red.
  • BEAM’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than AKRO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKRO’s TA Score shows that 3 TA indicator(s) are bullish while BEAM’s TA Score has 5 bullish TA indicator(s).

  • AKRO’s TA Score: 3 bullish, 5 bearish.
  • BEAM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than AKRO.

Price Growth

AKRO (@Biotechnology) experienced а -14.25% price change this week, while BEAM (@Biotechnology) price change was +8.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.84%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.37%.

Reported Earning Dates

AKRO is expected to report earnings on May 20, 2025.

BEAM is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+0.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKRO($3.35B) has a higher market cap than BEAM($2.38B). AKRO YTD gains are higher at: 51.402 vs. BEAM (14.839). BEAM has higher annual earnings (EBITDA): -160.83M vs. AKRO (-232.85M). BEAM has more cash in the bank: 926M vs. AKRO (717M). AKRO has less debt than BEAM: AKRO (36.4M) vs BEAM (162M). BEAM has higher revenues than AKRO: BEAM (350M) vs AKRO (0).
AKROBEAMAKRO / BEAM
Capitalization3.35B2.38B141%
EBITDA-232.85M-160.83M145%
Gain YTD51.40214.839346%
P/E RatioN/AN/A-
Revenue0350M-
Total Cash717M926M77%
Total Debt36.4M162M22%
TECHNICAL ANALYSIS
Technical Analysis
AKROBEAM
RSI
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 11 days ago
83%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
Aroon
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
77%
View a ticker or compare two or three
Ad is loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FVLZX33.680.28
+0.84%
Fidelity Advisor Value Z
RSLEX64.600.30
+0.47%
American Funds SMALLCAP World R4
GEGCX13.770.04
+0.29%
abrdn Emerging Markets C
LDMIX14.000.03
+0.21%
Lazard Developing Markets Equity Instl
DIEMX37.870.04
+0.11%
Driehaus Emerging Markets Growth Instl

AKRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKRO has been loosely correlated with ETNB. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if AKRO jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKRO
1D Price
Change %
AKRO100%
-3.55%
ETNB - AKRO
59%
Loosely correlated
-5.54%
AMLX - AKRO
39%
Loosely correlated
+7.20%
VTYX - AKRO
38%
Loosely correlated
-3.87%
MDGL - AKRO
37%
Loosely correlated
+0.80%
NAUT - AKRO
35%
Loosely correlated
+5.26%
More